Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Nature

• Publication date

  1998-03-05

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/32183PMID 9510252
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The distinctive features of influenza virus infection of dendritic cells.

  1998cited by this paper
• Class I–restricted Cross-Presentation of Exogenous Self-Antigens Leads to Deletion of Autoreactive CD8+ T Cells

  1997cited by this paper
• Susceptibility of mononuclear phagocytes to influenza A virus infection and possible role in the antiviral response

  1997cited by this paper
• The selective engulfment of apoptotic bodies by dendritic cells is mediated by the alpha(v)beta3 integrin and requires intracellular and extracellular calcium.

  1997cited by this paper
• Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules.

  1997cited by this paper
• Macrophage-dependent Apoptosis of CD4+ T Lymphocytes from HIV-infected Individuals Is Mediated by FasL and Tumor Necrosis Factor

  1997cited by this paper
• The selective engulfment of apoptotic bodies by dendritic cells is mediated by the αvβ3 integrin and requires intracellular and extracellular calcium

  1997cited by this paper
• Capture and processing of exogenous antigens for presentation on MHC molecules.

  1997cited by this paper
• Constitutive macropinocytosis allows TAP‐dependent major histocompatibility compex class I presentation of exogenous soluble antigen by bone marrow‐derived dendritic cells

  1997cited by this paper
• Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood.

  1996cited by this paper
• Constitutive class I-restricted exogenous presentation of self antigens in vivo

  1996cited by this paper
• Antibody‐targeted superantigen therapy induces tumor‐infiltrating lymphocytes, excessive cytokine production, and apoptosis in human colon carcinoma

  1996cited by this paper
• Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo

  1996cited by this paper
• Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability.

  1996cited by this paper
• Dendritic cells process exogenous viral proteins and virus‐like particles for class I presentation to CD8+ cytotoxic T lymphocytes

  1996cited by this paper
• A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules

  1995cited by this paper
• A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides.

  1995cited by this paper
• Generation, translocation, and presentation of MHC class I-restricted peptides.

  1995cited by this paper
• Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin

  1995cited by this paper
• Inactivated influenza virus, when presented on dendritic cells, elicits human CD8+ cytolytic T cell responses

  1995cited by this paper
• Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens.

  1994cited by this paper
• Programmed cell death (apoptosis) in human monocytes infected by influenza A virus.

  1994cited by this paper
• Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells.

  1994cited by this paper
• Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes

  1994cited by this paper
• Phagocytic processing of bacterial antigens for class I MHC presentation to T cells

  1993cited by this paper
• Hairy cell leukemia cells express CD1A antigen

  1988cited by this paper
• Recognition of influenza A matrix protein by HLA-A2-restricted cytotoxic T lymphocytes. Use of analogues to orientate the matrix peptide in the HLA-A2 binding site

  1988cited by this paper
• Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2

  1987cited by this paper
• The roles of interdigitating cells and natural killer cells in the rapid rejection of allogeneic lymphocytes

  1986cited by this paper
• An in situ immunogold method applied to the identification of plasma membrane-associated antigens of skin-infiltrating cells.

  1986cited by this paper
• Priming for a cytotoxic response to minor histocompatibility antigens: antigen specificity and failure to demonstrate a carrier effect.

  1977cited by this paper
• Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay

  1976cited by this paper

• The Immunopathogenesis of uveitis

  2026cites this paper
• NIR-II-responsive violet phosphorus nanoplatform converts intratumoral bacteria into immunoadjuvants for enhanced photothermal immunotherapy

  2026cites this paper
• The Inclusion of Dietary and Medicinal Mushrooms into Translational Oncology: Pros and Cons at the Molecular Level

  2026cites this paper
• Advanced extracellular vesicle immunotherapy

  2026cites this paper
• Microbial-induced trained immunity for cancer immunotherapy.

  2025cites this paper
• More Than a Cleanup Crew: The Expanding Biology of Efferocytosis.

  2025cites this paper
• Metabolic reprogramming in efferocytosis

  2025cites this paper
• Neoantigen identification and TCR-T therapy development for solid tumors: current advances and future perspectives

  2025cites this paper
• Inflammatory and Immunological Basis of Periodontal Diseases.

  2025cites this paper
• Vaccine adjuvants as stand-alone immunoprophylaxis in strategies for 100-day rapid responses to future pandemics.

  2025cites this paper
• Targeting pyroptosis for cancer immunotherapy: mechanistic insights and clinical perspectives

  2025cites this paper
• Harnessing Dendritic Cell Function in Hepatocellular Carcinoma: Advances in Immunotherapy and Therapeutic Strategies

  2025cites this paper
• Impact of pre-existing anti-replicase immunity on the efficacy of self-amplifying mRNA vaccines

  2025cites this paper
• Guardians on call: neutrophils, macrophages and dendritic cells in arthritis pathogenesis

  2025cites this paper
• Flagellin engineering enhances CAR-T cell function by reshaping tumor microenvironment in solid tumors

  2025cites this paper
• Combined surgical excision with skin grafting and thermal therapy for refractory plantar warts: a therapeutic approach in immunocompromised patients

  2025cites this paper
• The Role of Chronic Inflammation in Pediatric Cancer

  2025cites this paper
• Immunological landscape of solid cancer: Interplay between tumor and autoimmunity.

  2024cites this paper
• OV Modulators of the Paediatric Brain TIME: Current Status, Combination Strategies, Limitations and Future Directions

  2024cites this paper
• The role of dendritic cells in cancer immunity and therapeutic strategies.

  2024cites this paper
• TIPE2: A Candidate for Targeting Antitumor Immunotherapy.

  2024cites this paper
• Cytomegalovirus inhibitors of programmed cell death restrict antigen cross-presentation in the priming of antiviral CD8 T cells

  2024cites this paper
• El sistema inmune y su interminable batalla contra las células tumorales: reconocimiento, eliminación y evasión de la respuesta inmune

  2024cites this paper
• The Role of Exosomes in Central Immune Tolerance and Myasthenia Gravis

  2024cites this paper
• Traditional Chinese herbal medicine: harnessing dendritic cells for anti-tumor benefits

  2024cites this paper
• Differential Infiltration of Key Immune T-Cell Populations Across Malignancies Varying by Immunogenic Potential and the Likelihood of Response to Immunotherapy

  2024cites this paper
• The Spectrum of CAR Cellular Effectors: Modes of Action in Anti-Tumor Immunity

  2024cites this paper
• Efferocytosis in dendritic cells: an overlooked immunoregulatory process

  2024cites this paper
• Sema-3E/PlexinD1 axis modulates dendritic cell phenotypes and functions: Current status and future implications.

  2024cites this paper
• In situ endoscopic photodynamic therapy combined with immature DC vaccination induces a robust T cell response against peritoneal carcinomatosis

  2024cites this paper
• Innate immune cells: Key players of orchestra in modulating tumor microenvironment (TME)

  2024cites this paper
• Current Progress in the Science of Novel Adjuvant Nano-Vaccine-Induced Protective Immune Responses

  2024cites this paper
• Exploiting Leishmania—Primed Dendritic Cells as Potential Immunomodulators of Canine Immune Response

  2024cites this paper
• Different routes of MHC-I delivery to phagosomes and their consequences to CD8 T cell immunity.

  2023cites this paper
• The role of innate immune cells in the tumor microenvironment and research progress in anti-tumor therapy

  2023cites this paper
• Checkpoint TIPE2 Limits the Helper Functions of NK Cells in Supporting Antitumor CD8+ T Cells

  2023cites this paper
• Antigen presentation induced variation in ovalbumin sensitization between chicken and duck species.

  2023cites this paper
• Determinants for Antitumor and Protumor Effects of Programmed Cell Death

  2023cites this paper
• Radio-chemotherapy of glioblastoma cells promotes phagocytosis by macrophages in vitro.

  2023cites this paper
• Balancing act: the complex role of NK cells in immune regulation

  2023cites this paper
• Expression of Major Histocompatibility Complex during Neuronal Differentiation of Somatic Cell Nuclear Transfer-Human Embryonic Stem Cells

  2023cites this paper
• The show and tell of cross-presentation.

  2023cites this paper
• Unlocking antitumor immunity with adenosine receptor blockers

  2023cites this paper
• Natural polysaccharides exert anti-tumor effects as dendritic cell immune enhancers

  2023cites this paper
• Efferocytosis: a double-edged sword in microbial immunity

  2023cites this paper
• Dendritic cell subsets in cancer immunity and tumor antigen sensing

  2023cites this paper
• A critical assessment of the cellular defences of the avian respiratory system: are birds in general and poultry in particular relatively more susceptible to pulmonary infections/afflictions?

  2023cites this paper
• Peptide Vaccines as Therapeutic and Prophylactic Agents for Female-Specific Cancers: The Current Landscape

  2023cites this paper
• Breast Cancer Immunity: It is TIME for the Next Chapter.

  2023cites this paper
• Anti-Gene IGF-I Vaccines in Cancer Gene Therapy: A Review of a Case of Glioblastoma.

  2023cites this paper
• Pyroptosis: A road to next-generation cancer immunotherapy.

  2023cites this paper
• Cytotoxicity as a form of immunogenic cell death leading to efficient tumor antigen cross‐priming

  2023cites this paper
• Next-Generation Adjuvants: Applying Engineering Methods to Create and Evaluate Novel Immunological Responses

  2023cites this paper
• The pore-forming apolipoprotein APOL7C drives phagosomal rupture and antigen cross-presentation by dendritic cells

  2023cites this paper
• Mimicry of Tumour-Associated Carbohydrates: Is It a Promising Option for Cancer Treatment?

  2023cites this paper
• Effect of neoadjuvant chemotherapy on tumor immune infiltration in breast cancer patients: Systematic review and meta-analysis

  2023cites this paper
• Cytokine profiling in the acute phase of viral vaccination in Poultry

  2023cites this paper
• The biogenesis of the immunopeptidome.

  2023cites this paper
• Immunogenic cell stress and death in the treatment of cancer.

  2023cites this paper
• Engineering Diselenide-IR780 Homodimeric Nanoassemblies with Enhanced Photodynamic and Immunotherapeutic Effects for Triple-Negative Breast Cancer Treatment.

  2023cites this paper
• Targeting SLC7A11 improves efferocytosis by dendritic cells and wound healing in diabetes

  2022cites this paper
• Vakzinierungsstrategien beim Mammakarzinom

  2022cites this paper
• Tumor Treating Fields (TTFields) Concomitant with Immune Checkpoint Inhibitors Are Therapeutically Effective in Non-Small Cell Lung Cancer (NSCLC) In Vivo Model

  2022cites this paper
• Targeting the Phosphatidylserine-Immune Checkpoint with a Small-Molecule Maytansinoid Conjugate

  2022cites this paper
• T cell kinetics reveal expansion of distinct lung T cell subsets in acute versus in resolved influenza virus infection

  2022cites this paper
• MicroRNAs as immune regulators and biomarkers in tuberculosis

  2022cites this paper
• Tumour Derived Extracellular Vesicles: Challenging Target to Blunt Tumour Immune Evasion

  2022cites this paper
• Dendritic cell transfer for cancer immunotherapy.

  2022cites this paper
• Intraarterial Therapies for the Management of Hepatocellular Carcinoma

  2022cites this paper
• Activation of Cellular Players in Adaptive Immunity via Exogenous Delivery of Tumor Cell Lysates

  2022cites this paper
• Dendritic Cell-Based Immunotherapy in Hot and Cold Tumors

  2022cites this paper
• Autophagy, apoptosis, necroptosis, pyroptosis and netosis in pathogenesis of immune-inflammatory rheumatic diseases

  2022cites this paper
• DCs at the center of help: Origins and evolution of the three-cell-type hypothesis

  2022cites this paper
• Immunogenic Cell Death, DAMPs and Prothymosin α as a Putative Anticancer Immune Response Biomarker

  2022cites this paper
• Combined treatment with anti‐PSMA CAR NK‐92 cell and anti‐PD‐L1 monoclonal antibody enhances the antitumour efficacy against castration‐resistant prostate cancer

  2022cites this paper
• Engineered extracellular vesicles and their mimetics for cancer immunotherapy.

  2022cites this paper
• Gene Editing: a Powerful Tool for Cancer Immunotherapy

  2022cites this paper
• Research Progress on MicroRNA-155 Associated with Mycobacterium tuberculosis Infection

  2022cites this paper
• Identification of neoantigens for individualized therapeutic cancer vaccines

  2022cites this paper
• Local Hyperthermia Versus Cryotherapy for Treatment of Plantar Warts: A Prospective Multi-centre Non-randomized Concurrent Controlled Clinical Trial

  2022cites this paper
• Efferocytosis and Its Role in Inflammatory Disorders

  2022cites this paper
• The Interplay Between Epigenetic Regulation and CD8+ T Cell Differentiation/Exhaustion for T Cell Immunotherapy

  2022influential citation
• Importance of Efferocytosis in COVID-19 Mortality

  2022cites this paper
• Recent advances in organic and polymeric carriers for local tumor chemo-immunotherapy

  2022cites this paper
• Vaccine adjuvants to engage the cross-presentation pathway

  2022cites this paper
• Accelerated co-cultured dendritic cell (acDC) loaded with autologous apoptotic bodies might be a promising approach for antigen delivery

  2022cites this paper
• Trial watch: Dendritic cell (DC)-based immunotherapy for cancer

  2022cites this paper
• I’m Infected, Eat Me! Innate Immunity Mediated by Live, Infected Cells Signaling To Be Phagocytosed

  2021cites this paper
• Unraveling Cell Death Pathways during Malaria Infection: What Do We Know So Far?

  2021cites this paper
• Defining Immunogenic and Radioimmunogenic Tumors

  2021cites this paper
• Apoptotic Bodies: Mechanism of Formation, Isolation and Functional Relevance.

  2021cites this paper
• Emerging concepts in the science of vaccine adjuvants

  2021cites this paper
• DNA-launched RNA replicon vaccines induce potent anti-SARS-CoV-2 immune responses in mice

  2021cites this paper
• Deletion of BCG_2432c from the Bacillus Calmette‐Guérin vaccine enhances autophagy‐mediated immunity against tuberculosis

  2021cites this paper
• Apoptosis-induced translocation of centromere protein F in its corresponding autoantibody production in hepatocellular carcinoma

  2021cites this paper
• Macrophage and neutrophil death programs differentially confer resistance to tuberculosis.

  2021cites this paper
• Trp2 Peptide-Assembled Nanoparticles with Intrinsically Self-Chelating 64Cu Properties for PET Imaging Tracking and Dendritic Cell-Based Immunotherapy against Melanoma.

  2021cites this paper
• The role of dendritic cells in cancer and anti-tumor immunity.

  2021cites this paper
• Neoantigen‐based vaccines as a promising strategy in cancer immunotherapeutics

  2021cites this paper
• A Guide to Nucleic Acid Vaccines in the Prevention and Treatment of Infectious Diseases and Cancers: From Basic Principles to Current Applications

  2021cites this paper